FutureHouse debuts AI science agents, inviting skeptical scientists to try for free

Andrew Dunn

Senior Biopharma Correspondent

Open source doesn’t necessarily mean easy access, and now the nonprofit FutureHouse is trying to bridge that gap for AI tools in science by launching …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FutureHouse debuts AI science agents, inviting skeptical scientists to try for free

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FDA asks Covid vaccine makers to add more myocarditis data to labels

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Updated: Eikon Therapeutics cuts staff for the second time in less than two years

FDA announces efforts to facilitate drug importation from Canada

FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Fu­ture­House de­buts AI sci­ence agents, invit­ing skep­ti­cal sci­en­tists to try for free

Senior Biopharma Correspondent

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FutureHouse debuts AI science agents, inviting skeptical scientists to try for free